SAN DIEGO–(BUSINESS WIRE)–May 8, 2006–Imagenetix (OTCBB:IAGX – News) today announced the successful completion of in vitro studies demonstrating the significant inhibitory function of its novel pharma compound, 1-tetradecanol complex (1-TDC). The main findings include: 1-TDC significantly inhibited the growth of Actinomyces viscosus, a microbe that has been shown to play a major role in oral [...]
{ Comments on this entry are closed }